Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Philip, Maes"'
Autor:
Jessica van Hattem, Philip Maes, Tonya Marianne Esterhuizen, Ann Devos, Martin Ruppert, Jaques van Heerden
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 19, p 6287 (2023)
Limited data regarding erythrocytapheresis in children, adolescents, and young adults have been published. The aim of this study was to evaluate erythrocytapheresis, either as a standalone therapy or in combination with iron chelation therapy, in chi
Externí odkaz:
https://doaj.org/article/e5f0643025a045dead5c40d99738db3e
Autor:
Anthe Foubert, Nathalie Anne Roussel, Valérie-Anne Chantrain, Philip Maes, Lies Durnez, Sébastien Lobet, Catherine Lambert, Cédric Hermans, Mira Meeus
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2479 (2023)
In people with haemophilia (PwH), joint pain is a major comorbidity that is often overlooked and under-treated. It is believed that, to ensure the most successful outcome, pain management should be tailored to the predominant pain phenotype (i.e., no
Externí odkaz:
https://doaj.org/article/99385194680d4f7bac0492b637253d9c
Autor:
Tamara Hamlish, Mary Pasquinelli, Nicole Gastala, Michael Huber, Deborah Manst, Kristin Andersen, Jennie B. Jarrett, Christine Neeb, Jason Tuite, Philip Maes, Choa Sung, Judes Fleurimont, Lawrence Feldman
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 8, Iss , Pp 100196- (2022)
The recent decline in cancer mortality combined with the surge in cases of opioid use disorder (OUD) has increased the complexity of pain management for long-term cancer survivors. We describe here the case of a 69-year-old man with a history of subs
Externí odkaz:
https://doaj.org/article/f7a5b59f41fc441bbcb5c160912fd697
Autor:
Cristina Santoro, Beng Fuh, Phu Quoc Le, Philip Maes, Rubén Berrueco, Eva Maria Mingot‐Castellano, Sylvia von Mackensen, Claudia Tueckmantel, Jose Francisco Cabre‐Marquez, Michael Wang
Publikováno v:
European journal of haematology
Objectives To report the final results of the 2-year TAURUS study, assessing weekly prophylaxis dosing regimens of octocog alfa (Kovaltry (R)/BAY 81-8973) used in standard clinical practice in patients with moderate-to-severe haemophilia A. Methods T
Autor:
Mark T Reding, Maria Elisa Mancuso, Suchitra Acharya, Sanjay Ahuja, Maria Teresa Álvarez-Román, Lisa N Boggio, Meera B. Chitlur, Abraham Salvador Majluf-Cruz, Amy L Dunn, Miguel Escobar, Annie Harroche, Maissaa Janbain, Craig M. Kessler, Philip Maes, Catherine E. McGuinn, Danielle Nance, Ulrike Nowak-Göttl, Robert F. Sidonio, Jr., Duc Q Tran, Michael Wang, Jerzy Windyga, Hongying Wang, Thomas Wilkinson, Steven W. Pipe
Publikováno v:
Blood. 140:5597-5599
Autor:
Sébastien Lobet, Catherine Lambert, Anthe Foubert, Valérie‐Anne Chantrain, Nathalie Roussel, Mira Meeus, Ann Devos, Philip Maes, Cedric Hermans, Massimo Penta
Publikováno v:
Haemophilia
IntroductionTo assess activity limitations in people with haemophilia (PwH), the self-reported Haemophilia Activity List (HAL) is widely employed, despite several methodological limitations impacting the interpretation of categorical scores. Modern p
Autor:
Veerle Mondelaers, Stefan Suciu, Barbara De Moerloose, Alina Ferster, Françoise Mazingue, Geneviève Plat, Karima Yakouben, Anne Uyttebroeck, Patrick Lutz, Vitor Costa, Nicolas Sirvent, Emmanuel Plouvier, Martine Munzer, Maryline Poirée, Odile Minckes, Frédéric Millot, Dominique Plantaz, Philip Maes, Claire Hoyoux, Hélène Cavé, Pierre Rohrlich, Yves Bertrand, Yves Benoit
Publikováno v:
Haematologica, Vol 102, Iss 10 (2017)
Asparaginase is an essential component of combination chemotherapy for childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma. The value of asparaginase was further addressed in a group of non-very high-risk patients by comparing prolonged (
Externí odkaz:
https://doaj.org/article/302c2bf06fcf45ca8182436bee24ce00
BAY 81‐8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study
Autor:
Beng Fuh, Eva Maria Mingot‐Castellano, Philip Maes, Phu Quoc Lê, Sylvia von Mackensen, Alexander Solms, Michael Wang, Rubén Berrueco, Cristina Santoro
Publikováno v:
European Journal of Haematology
European journal of haematology
European journal of haematology
Objectives To report interim data from TAURUS, a study assessing real-world prophylactic treatment with unmodified, full-length recombinant FVIII BAY 81-8973 (Kovaltry(R); Bayer) indicated for haemophilia A. Methods TAURUS (NCT02830477) is an interna
Autor:
Emna, Gouider, Anna, Klukowska, Philip, Maes, Helen, Platokouki, Sonia, Pujol, Céline, Henriet, Françoise, Bridey, Jenny, Goudemand
Publikováno v:
Blood Transfus
BACKGROUND: Plasma-derived von Willebrand factor (VWF) (Wilfactin(®), LFB, France) was developed for prophylaxis and treatment of haemorrhages in both adults and adolescents with von Willebrand disease (VWD). Replacement therapy in paediatric patien
Autor:
Michael Huber, Nicole Gastala, Mary Pasquinelli, Jennie Jarrett, Tamara Hamlish, Judes Fleurimont, Philip Maes, Kristin Andersen, Deborah Manst, Tondalaya Henry, Lawrence Feldman
Publikováno v:
Journal of Pain and Symptom Management. 63:893-894